LINC02118: A Long Intergenic Non-Protein-Coding RNA (G105378960)

Target Name: LINC02118

NCBI ID: G105378960

LINC02118

Other Name(s): long intergenic non-protein coding RNA 2118 | Long intergenic non-protein coding RNA 2118

LINC02118: A Long Intergenic Non-Protein-Coding RNA

LINC02118 is a long non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target or biomarker. It is a transcribed RNA molecule that is longer than 200 nucleotides and is not associated with any known protein coding genes. LINC02118 has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. Its function and regulation are still poorly understood, but its potential role as a drug target or biomarker is an exciting area of research.

Structure and Expression

LINC02118 is a 199-nt RNA molecule that is expressed in various tissues and cells. It is primarily expressed in the brain and testes, and also expressed in the liver, muscle, and placenta. The expression level of LINC02118 varies between different tissues and cells, with higher levels in the brain and lower levels in the liver. The expression pattern of LINC02118 is highly conserved across different species, which suggests that it may be a universal gene.

Function and Mechanism of Action

LINC02118 has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion. It is involved in the formation of tight junctions, which are a type of cell-cell adhesion that is essential for the proper functioning of tissues and organs. LINC02118 has been shown to regulate the formation of tight junctions by interacting with the transcription factor, Snail.

LINC02118 has also been shown to be involved in the regulation of cell migration and invasion. It has been shown to play a role in the migration of cancer cells and in the invasion of cancer cells into surrounding tissues. This may have important implications for the development of cancer.

LINC02118 may also be involved in the regulation of cellular processes related to cell survival. It has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached their maximum lifespan. LINC02118 has been shown to regulate the apoptosis of cancer cells, which may have implications for the development of cancer.

Potential Therapeutic Use

The potential therapeutic use of LINC02118 is its potential as a drug target. LINC02118 has been shown to interact with several protein molecules, including the protein, PDGF-B. This suggests that LINC02118 may be a good candidate for drugs that target the PDGF signaling pathway.

LINC02118 has also been shown to interact with the protein, NF-kappa-B. This suggests that LINC02118 may be a good candidate for drugs that target the NF-kappa-B signaling pathway.

In addition to its potential as a drug target, LINC02118 may also be a useful biomarker for the diagnosis and prognosis of certain diseases. The regulation of LINC02118 has been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that LINC02118 may be a useful biomarker for the diagnosis and prognosis of these diseases.

Conclusion

LINC02118 is a long non-protein-coding RNA molecule that has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion. Its function and regulation are still poorly understood, but its potential as a drug target or biomarker is an exciting area of research. Further studies are needed to fully understand the role of LINC02118 in

Protein Name: Long Intergenic Non-protein Coding RNA 2118

The "LINC02118 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02118 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets